$NTIP
NETWORK-1 TECHNOLOGIES, INC. Stock $ntip

$ntip Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000107261323000275 Filed on March 30, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$537.0K	$0.00
YoY Change		-100.0%
Cost Of Revenue	$151.0K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Gross Profit	$386.0K	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Gross Profit Margin	71.88%
Selling, General & Admin	$1.079M	$1.251M	$3.587M
YoY Change	31.27%	29.37%	-10.35%
% of Gross Profit	279.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$83.00K	$83.00K	$316.0K
YoY Change	10.67%	12.16%	7.12%
% of Gross Profit	21.5%
Operating Expenses	$1.313M	$1.334M	$3.903M
YoY Change	46.38%	28.15%	-9.15%
Operating Profit	-$776.0K	-$1.334M	-$3.903M
YoY Change	-13.49%	62.48%	-119.93%
Interest Expense	$674.0K	$651.0K	$3.552M
YoY Change	-255.3%	65000.0%	2206.49%
% of Operating Profit
Other Income/Expense, Net	$674.0K		$3.823M
YoY Change	-255.3%		2382.47%
Pretax Income	-$102.0K	-$683.0K	-$80.00K
YoY Change	-92.34%	-16.71%	-100.41%
Income Tax	-$153.0K	$459.0K	$607.0K
% Of Pretax Income
Net Earnings	-$623.0K	-$1.708M	-$2.326M
YoY Change	-52.52%	75.0%	-116.29%
Net Earnings / Revenue	-116.01%
Basic Earnings Per Share	-$0.03		-$0.10
Diluted Earnings Per Share	-$0.03	-$0.07	-$0.10
COMMON SHARES
Basic Shares Outstanding	23.82M shares	23.89M shares	23.83M shares
Diluted Shares Outstanding	23.87M shares		23.83M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$46.84M	$48.44M	$48.44M
YoY Change	-17.15%	-18.76%	-18.76%
Cash & Equivalents	$9.919M	$13.45M	$13.45M
Short-Term Investments	$36.92M	$34.99M	$34.99M
Other Short-Term Assets	$119.0K	$348.0K	$525.0K
YoY Change	7.21%	132.0%	250.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$47.14M	$48.96M	$48.96M
YoY Change	-16.79%	-18.08%	-18.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$145.0K	$161.0K	$161.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$6.578M	$7.252M	$7.252M
YoY Change	104.41%	173.56%	98.63%
Other Assets	$13.00K	$0.00	$0.00
YoY Change	0.0%	-100.0%	-100.0%
Total Long-Term Assets	$8.245M	$9.005M	$9.005M
YoY Change	62.82%	78.39%	78.39%
TOTAL ASSETS
Total Short-Term Assets	$47.14M	$48.96M	$48.96M
Total Long-Term Assets	$8.245M	$9.005M	$9.005M
Total Assets	$55.38M	$57.97M	$57.97M
YoY Change	-10.26%	-10.57%	-10.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$601.0K	$507.0K	$507.0K
YoY Change	22.65%	10.46%	10.46%
Accrued Expenses	$517.0K	$983.0K	$983.0K
YoY Change	-9.14%	41.03%	41.03%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.233M	$1.605M	$1.605M
YoY Change	-69.26%	-60.93%	-60.93%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$77.00K	$94.00K	$94.00K
YoY Change
Total Long-Term Liabilities	$77.00K	$94.00K	$94.00K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.233M	$1.605M	$1.605M
Total Long-Term Liabilities	$77.00K	$94.00K	$94.00K
Total Liabilities	$2.318M	$2.860M	$2.860M
YoY Change	-43.64%	-38.65%	-38.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.26M	-$12.06M
YoY Change		87.54%
Common Stock	$239.0K	$239.0K
YoY Change		0.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$53.06M	$55.11M	$55.11M
YoY Change
Total Liabilities & Shareholders Equity	$55.38M	$57.97M	$57.97M
YoY Change	-10.26%	-10.57%	-10.57%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$623.0K	-$1.708M	-$2.326M
YoY Change	-52.52%	75.0%	-116.29%
Depreciation, Depletion And Amortization	$83.00K	$83.00K	$316.0K
YoY Change	10.67%	12.16%	7.12%
Cash From Operating Activities	-$290.0K	-$256.0K	-$5.436M
YoY Change	-61.28%	150.98%	-127.88%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$524.0K
YoY Change		-100.0%	-618.81%
Acquisitions
YoY Change
Other Investing Activities	-$1.659M	-$7.033M	-$21.75M
YoY Change	-408.94%	-392.92%	-802.65%
Cash From Investing Activities	-$1.659M	-$7.033M	-$22.27M
YoY Change	-12861.54%	-394.76%	-843.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$534.0K
YoY Change			-149.58%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.580M	-427.0K	-$3.342M
YoY Change	21.35%	-55.52%	-4.54%
NET CHANGE
Cash From Operating Activities	-$290.0K	-256.0K	-$5.436M
Cash From Investing Activities	-$1.659M	-7.033M	-$22.27M
Cash From Financing Activities	-$1.580M	-427.0K	-$3.342M
Net Change In Cash	-$3.529M	-7.716M	-$31.05M
YoY Change	73.16%	-682.78%	-263.48%
FREE CASH FLOW
Cash From Operating Activities	-$290.0K	-$256.0K	-$5.436M
Capital Expenditures		$0.00	$524.0K
Free Cash Flow		-$256.0K	-$5.960M
YoY Change		194.25%	-130.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001065078
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Prepaid Taxes PrepaidTaxes		usd
CY2022Q4	nssi	Convertible Note Investments ConvertibleNoteInvestments		usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit		usd
CY2022Q4	nssi	Accrued Contingency Fees And Related Costs AccruedContingencyFeesAndRelatedCosts		usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021	nssi	Gain On Equity Method Investment GainOnEquityMethodInvestment		usd
CY2021	nssi	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset		usd
CY2021	nssi	Gain On Equity Method Investment GainOnEquityMethodInvestment		usd
CY2021	nssi	Accrued Interest On Convertible Note AccruedInterestOnConvertibleNote		usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes		usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
CY2022	nssi	Convertible Note Investment ConvertibleNoteInvestment		usd
CY2022	us-gaap	Interest Paid InterestPaid		usd
CY2021	us-gaap	Interest Paid InterestPaid		usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021	nssi	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability		usd
CY2021	nssi	Non Cash Conversion Of Note Receivable NonCashConversionOfNoteReceivable		usd
CY2022	us-gaap	Revenues Revenues		usd
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2021Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards		usd
CY2021Q4	nssi	Deferred Tax Assets Stock Options And Rsu DeferredTaxAssetsStockOptionsAndRsu		usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability		usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	1-15288
CY2022	dei	Entity Registrant Name EntityRegistrantName	NETWORK-1 TECHNOLOGIES, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-3027591
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	65 Locust Avenue
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Third Floor
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	New Canaan
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06840
CY2022	dei	City Area Code CityAreaCode	(203)
CY2022	dei	Local Phone Number LocalPhoneNumber	920-1055
CY2022	dei	Security12b Title Security12bTitle	Common Stock $.01 par value
CY2022	dei	Trading Symbol TradingSymbol	NTIP
CY2022	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	39885677	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23817505	shares
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Marcum LLP
CY2022	dei	Auditor Location AuditorLocation	New York, New York
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13448000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44497000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	34991000	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	15126000	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	177000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	348000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	150000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	48964000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	59773000	usd
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1592000	usd
CY2021Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1384000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	7252000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2651000	usd
CY2021Q4	nssi	Convertible Note Investments ConvertibleNoteInvestments	1000000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	161000	usd
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	13000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	9005000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	5048000	usd
CY2022Q4	us-gaap	Assets Assets	57969000	usd
CY2021Q4	us-gaap	Assets Assets	64821000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	507000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	459000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	115000	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2952000	usd
CY2021Q4	nssi	Accrued Contingency Fees And Related Costs AccruedContingencyFeesAndRelatedCosts	137000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	317000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	380000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	587000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	180000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	79000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1605000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4108000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1161000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	554000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	94000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2860000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4662000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23863639	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23863639	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23792212	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23792212	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	239000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	238000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	66939000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	66361000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12055000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6428000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	55109000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	60159000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57969000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	64821000	usd
CY2021	us-gaap	Revenues Revenues	36029000	usd
CY2021	nssi	Cost Of Revenues CostOfRevenues	12147000	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	809000	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	1500000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2778000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2501000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	316000	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	295000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	3903000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	16443000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-3903000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	19586000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1020000	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	327000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	271000	usd
CY2022	nssi	Gain On Equity Method Investment GainOnEquityMethodInvestment	3883000	usd
CY2022	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-1351000	usd
CY2021	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-173000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3823000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	154000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-80000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	19740000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2952000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	607000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1508000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	607000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4460000	usd
CY2022	nssi	Loss Income Before Share Of Net Losses Of Equity Method Investee LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee	-687000	usd
CY2021	nssi	Loss Income Before Share Of Net Losses Of Equity Method Investee LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee	15280000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-1639000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-999000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2326000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14281000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23825917	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24136821	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23825917	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24530568	shares
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.10
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.10
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2326000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14281000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-2000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-2000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2328000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14279000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2326000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14281000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	316000	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	295000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	585000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	238000	usd
CY2022	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-1639000	usd
CY2021	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-999000	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	607000	usd
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	1508000	usd
CY2022	nssi	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	43000	usd
CY2022	nssi	Gain On Equity Method Investment GainOnEquityMethodInvestment	3883000	usd
CY2022	nssi	Accrued Interest On Convertible Note AccruedInterestOnConvertibleNote	86000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	271000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-880000	usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-148000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	208000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	30000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	167000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	48000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-142000	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-2837000	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2952000	usd
CY2022	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	13000	usd
CY2021	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	8000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-31000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	242000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-758000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5436000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	19499000	usd
CY2022	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-13156000	usd
CY2021	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-17154000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	33903000	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	13059000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	524000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	101000	usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1000000	usd
CY2021	nssi	Convertible Note Investment ConvertibleNoteInvestment	1000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22271000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2994000	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2453000	usd
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2410000	usd
CY2022	nssi	Value Of Shares Delivered To Fund Withholding Taxes ValueOfSharesDeliveredToFundWithholdingTaxes	355000	usd
CY2021	nssi	Value Of Shares Delivered To Fund Withholding Taxes ValueOfSharesDeliveredToFundWithholdingTaxes	14000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	534000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1077000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3342000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3501000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-31049000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	18992000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44497000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25505000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13448000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44497000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3004000	usd
CY2022	nssi	Accrued Dividend Rights On Restricted Stock Units AccruedDividendRightsOnRestrictedStockUnits	37000	usd
CY2021	nssi	Accrued Dividend Rights On Restricted Stock Units AccruedDividendRightsOnRestrictedStockUnits	20000	usd
CY2022	nssi	Right Of Use Asset Obtained In Exchange For Lease Liability RightOfUseAssetObtainedInExchangeForLeaseLiability	204000	usd
CY2022	nssi	Non Cash Conversion Of Note Receivable NonCashConversionOfNoteReceivable	1086000	usd
CY2022	us-gaap	Gain Contingency Patents Found Infringed Upon Number GainContingencyPatentsFoundInfringedUponNumber	97	integer
CY2022	nssi	Expired Patents ExpiredPatents	52	integer
CY2022	nssi	Foreign Patents Owned By Company ForeignPatentsOwnedByCompany	8	integer
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zT2pw0Eh4lY1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 27.35pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>[2]</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_866_zZt5VJJORZJ">Use of Estimates and Assumptions</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of the Company’s consolidated financial statements primarily include costs related to the Company’s assertion of litigation, the valuation of the Company’s patent portfolios, stock-based compensation, the recoverability of deferred tax assets and carrying value of the Company’s equity method investments. Actual results could be materially different from those estimates, upon which the carrying values were based. </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Certain amounts recorded to reflect the Company’s share of income or losses of its equity method investee, accounted for under the equity method, are based on estimates and the unaudited results of operations of the equity method investee and may require adjustment in the future when the audit is complete. The Company reports its share of the results of its equity method investee on a one quarter lag basis.</span></p>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2021Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1715000	usd
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	8109000	usd
CY2022Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	2976000	usd
CY2021Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	0	usd
CY2021	us-gaap	Revenues Revenues	36029000	usd
CY2022	nssi	Increase In Net Losses Of Equity Method Investee IncreaseInNetLossesOfEquityMethodInvestee	398000	usd
CY2022	nssi	Decrease In Basic And Diluted Earnings DecreaseInBasicAndDilutedEarnings	0.02
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zS8qU84IDvg5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black"/> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"> <tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.35in"><span style="font: small-caps 10pt Times New Roman, Times, Serif; color: Black"><b>[16]</b></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_86C_zbwgUCXoG8C2">Reclassifications</span></b></span></td></tr> </table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black"/></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 0.35in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; color: Black">Stock-based compensation in the 2021 consolidated statements of operations and comprehensive income (loss) have been recast and reclassified to conform to the current year’s presentation. </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; color: Black"> </span></p>
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8473000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7949000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6881000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6565000	usd
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1592000	usd
CY2021Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1384000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	316000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	295000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	266000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	120000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	120000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	120000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	119000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	847000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1592000	usd
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	625000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	12500	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23825917	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24136821	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	393747	shares
CY2022	nssi	Weightedaverage Common Shares Outstanding Diluted WeightedaverageCommonSharesOutstandingDiluted	23825917	shares
CY2021	nssi	Weightedaverage Common Shares Outstanding Diluted WeightedaverageCommonSharesOutstandingDiluted	24530568	shares
CY2022	nssi	Restricted Stock Units Excluded From Computation Of Diluted Income Per Share Because Effect Of Inclusion Would Have Been Antidilutive RestrictedStockUnitsExcludedFromComputationOfDilutedIncomePerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive	625000	shares
CY2021	nssi	Restricted Stock Units Excluded From Computation Of Diluted Income Per Share Because Effect Of Inclusion Would Have Been Antidilutive RestrictedStockUnitsExcludedFromComputationOfDilutedIncomePerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive	12500	shares
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	144000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2808000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2952000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	56000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	83000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	551000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1425000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	607000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1508000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	607000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4460000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	477000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	331000	usd
CY2022Q4	nssi	Deferred Tax Assets Stock Options And Rsu DeferredTaxAssetsStockOptionsAndRsu	30000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	838000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	0	usd
CY2022Q4	nssi	Deferred Tax Liability DeferredTaxLiability	-1161000	usd
CY2021Q4	nssi	Deferred Tax Liability DeferredTaxLiability	-554000	usd
CY2022Q4	nssi	Deferred Tax Assets Liability DeferredTaxAssetsLiability	-1161000	usd
CY2021Q4	nssi	Deferred Tax Assets Liability DeferredTaxAssetsLiability	-554000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2168000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	838000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	838000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1161000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0840	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0169	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.4879	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0128	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0111	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0043	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.3534	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.2380	pure
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	12500	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.36
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	162500	shares
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.25
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	670000	shares
CY2022	nssi	Issuance Weightedaverage Grant Date Fair Value IssuanceWeightedaverageGrantDateFairValue	1.92
CY2021	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	45000	shares
CY2021	nssi	Issuance Weightedaverage Grant Date Fair Value IssuanceWeightedaverageGrantDateFairValue	3.51
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	57500	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.73
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	195000	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.47
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	625000	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.87
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	12500	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.36
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	0	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	815000	usd
CY2022	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	3883000	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1000000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	86000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	271000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15246000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	11133000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	17913000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	10384000	usd
CY2022Q1	nssi	Hft Patent Acqusition Cash At Closing HftPatentAcqusitionCashAtClosing	500000	usd
CY2022Q1	nssi	Obligation To Pay Hft Seller Additional Cash Based On Achieving Certain Milestones ObligationToPayHftSellerAdditionalCashBasedOnAchievingCertainMilestones	500000	usd
CY2022Q1	nssi	Contingent Common Stock Issued Upon Achieving Certain Milestones ContingentCommonStockIssuedUponAchievingCertainMilestones	375000	usd
CY2022Q1	nssi	First50 Million First50Million	0.15	pure
CY2022Q1	nssi	Greater Than50 Million GreaterThan50Million	0.175	pure
CY2022Q4	nssi	Obligated To Pay Seller Net Proceed Percentage ObligatedToPaySellerNetProceedPercentage	0.125	pure
CY2022Q4	nssi	First125 Million First125Million	0.10	pure
CY2022Q4	nssi	Next125 Million Next125Million	0.15	pure
CY2022Q4	nssi	Over250 Million Over250Million	0.20	pure
	nssi	Recognition Net Proceeds Payment Related To Mirror Worlds Patents RecognitionNetProceedsPaymentRelatedToMirrorWorldsPatents	3127000	usd
CY2022Q4	nssi	First100 First100	0.14	pure
CY2022Q4	nssi	Next100 Next100	0.05	pure
CY2022Q4	nssi	Aadditional Consideration AadditionalConsideration	250000	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	78000	usd
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	102000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.042	pure
CY2022Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P3Y
CY2022Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P2Y3M18D
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	161000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	79000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	94000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	173000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	48000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	82000	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	128000	usd
CY2022	us-gaap	Lease Cost LeaseCost	130000	usd
CY2021	us-gaap	Lease Cost LeaseCost	128000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	83000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	73000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	24000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	180000	usd
CY2022Q4	nssi	Operating Leases Imputed Interest OperatingLeasesImputedInterest	-7000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	173000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	228530	shares
CY2022	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	531000	usd
CY2022	nssi	Weighted Average Price Per Share Common Stock Subject To Repurchase WeightedAveragePricePerShareCommonStockSubjectToRepurchase	2.33
	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	9212664	shares
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	17758000	usd
	nssi	Weighted Average Price Per Share Common Stock Subject To Repurchase WeightedAveragePricePerShareCommonStockSubjectToRepurchase	1.93
CY2022	nssi	Dividends Per Share Annual DividendsPerShareAnnual	0.10
CY2022	nssi	Dividends Per Share DividendsPerShare	0.05

Files In Submission

Name	View Source	Status
nssi-20221231_pre.xml	Edgar Link	unprocessable
0001072613-23-000275-index-headers.html	Edgar Link	pending
0001072613-23-000275-index.html	Edgar Link	pending
0001072613-23-000275.txt	Edgar Link	pending
0001072613-23-000275-xbrl.zip	Edgar Link	pending
exh21-1_18704.htm	Edgar Link	pending
exh23-1_18704.htm	Edgar Link	pending
exh23-2_18704.htm	Edgar Link	pending
exh31-1_18704.htm	Edgar Link	pending
exh31-2_18704.htm	Edgar Link	pending
exh32-1_18704.htm	Edgar Link	pending
exh32-2_18704.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
network1_10k-123122.htm	Edgar Link	pending
nssi-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nssi-20221231_cal.xml	Edgar Link	unprocessable
nssi-20221231_def.xml	Edgar Link	unprocessable
nssi-20221231_lab.xml	Edgar Link	unprocessable
network1_10k-123122_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NTIP
NETWORK-1 TECHNOLOGIES, INC. Stock $ntip

2023 Q1 Form 10-K Financial Statement

#000107261323000275 Filed on March 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTIP NETWORK-1 TECHNOLOGIES, INC. Stock $ntip

2023 Q1 Form 10-K Financial Statement

#000107261323000275 Filed on March 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTIP
NETWORK-1 TECHNOLOGIES, INC. Stock $ntip